Barclays analyst Luke Sergott lowered the firm’s price target on Charles River (CRL) to $200 from $215 and keeps an Overweight rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRL:
- Strategic Review at Charles River Laboratories Raises Deal Uncertainty, Execution Risks, and Shareholder Value Concerns
- Charles River Labs Eyes Margin Gains Amid Flat Growth
- Charles River Labs Appoints Glenn Coleman as New CFO
- Charles River names Glenn Coleman CFO, Kerry Dailey chief legal officer
- Charles River appoints Glenn Coleman as CFO, Kerry Dailey as CLO